Interested in learning about the primary grant mechanisms that NIH uses for multi-component proposals? Below are descriptions of those mechanisms and a table of currently funded centers at UCSF.
Research Program Projects (P01) support a broadly based, multidisciplinary, often long-term research program which has a specific major objective or a basic theme. A program project generally involves the organized efforts of relatively large groups, members of which are conducting research projects designed to elucidate the various aspects or components of this objective. Each research project is usually under the leadership of an established investigator. The grant can provide support for certain basic resources used by these groups in the program, including clinical components, the sharing of which facilitates the total research effort. A program project is directed toward a range of problems having a central research focus, in contrast to the usually narrower thrust of the traditional research project. Each project supported through this mechanism should contribute or be directly related to the common theme of the total research effort. These scientifically meritorious projects should demonstrate an essential element of unity and interdependence, i.e., a system of research activities and projects directed toward a well-defined research program goal.
Currently Funded P01s at UCSF (last updated July 2019)
Award Number |
Awarding IC |
Title |
PI |
Awarded Period |
---|---|---|---|---|
NIA |
DEGENERATIVE AND DEMENTING DISEASES OF AGING |
1-APR-1997 – 31-MAR-2020 |
||
NIA |
FRONTOTEMPORAL DEMENTIA: GENES, IMAGES, AND EMOTIONS |
1-APR-2002 – 31-MAY-2022 |
||
NIAID |
DEFINING THE UNIQUE PROPERTIES OF THE DISTINCT SIGNALING MACHINERY USED BY THE TCR |
15-JUL-2011 – 30-JUN-2021 |
||
NIAID |
DISRUPTION OF T CELL TOLERANCE IN TYPE 1 DIABETES |
8-JUN-2016 – 31-MAY-2021 |
||
NCI |
IMAGING AND TISSUE CORRELATES TO OPTIMIZE MANAGEMENT OF GLIOBLASTOMA |
1-DEC-2005 – 31-JUL-2019 |
||
NCI |
I-SPY2 +: EVOLVING THE I-SPY 2 TRIAL TO INCLUDE MRI-DIRECTED, ADAPTIVE SEQUENTIAL TREATMENT TO OPTIMIZE BREAST CANCER OUTCOMES |
8-SEP-2017 – 31-AUG-2022 |
||
NIGMS |
MAPPING THE CONFORMATIONAL CYCLE OF TRANSMEMBRANE TRANSPORTERS |
1-AUG-2015 – 31-JUL-2020 |
||
NICHD |
NOVEL STRATEGIES TO PREVENT MALARIA AND IMPROVE MATERNAL-CHILD HEALTH IN AFRICA |
1-AUG-2008 – 30-JUN-2019 |
||
NHLBI |
INNATE AND ADAPTIVE IMMUNE RESPONSES IN TH2-HIGH ASTHMA |
15-AUG-2012 – 31-MAY-2019 |
||
NINDS |
REPAIR AFTER ISCHEMIC IN THE TERM NEWBORN |
1-JAN-2014 – 31-DEC-2019 |
||
NINDS |
REGULATION OF CELLULAR PATHWAYSIN HUMAN BRAIN DEVELOPMENT |
1-JUL-2014 – 30-JUN-2019 |
Center Core Grants (P30) support shared resources and facilities for categorical research by a number of investigators from different disciplines who provide a multidisciplinary approach to a joint research effort or from the same discipline who focus on a common research problem. The core grant is integrated with the center's component projects or program projects, though funded independently from them. This support, by providing more accessible resources, is expected to assure a greater productivity than from the separate projects and program projects.
Currently Funded P30s at UCSF (last updated July 2019)
Award Number |
Awarding IC |
Title |
PI |
Awarded Period |
NIA |
CENTER FOR AGING IN DIVERSE COMMUNITIES: ENDING HEALTH INEQUITIES IN OLDER ADULTS |
30-SEP-2017 – 30-JUN-2023 |
||
NIA |
UCSF OLDER AMERICANS INDEPENDENCE CENTER |
15-JUL-2013 – 30-JUN-2023 |
||
NIAID |
UCSF-GLADSTONE CENTER FOR AIDS RESEARCH |
1-MAR-1997 – 31-AUG-2022 |
||
NIAMS |
UCSF CORE CENTER FOR MUSCULOSKELETAL BIOLOGY AND MEDICINE |
1-JUL-2014 – 30-JUN-2019 |
||
NIAMS |
RESOURCE-BASED CENTER FOR THE ADVANCEMENT OF PRECISION MEDICINE IN RHEUMATOLOGY |
21-SEP-2016 – 31-AUG-2021 |
||
NCI |
CANCER CENTER SUPPORT GRANT |
5-AUG-1999 – 21-MAY-2023 |
||
NIDA |
DRUG DEPENDENCE CLINICAL RESEARCH PROGRAM |
1-SEP-1999 – 30-JUN-2020 |
||
NIDDK |
UCSF LIVER CENTER |
1-DEC-1996 – 31-MAY-2023 |
||
NIDDK |
DIABETES RESEARCH CENTER |
1-SEP-2002 – 31-MAR-2020 |
||
NIDDK |
NOVEL SMALL-MOLECULE THERAPIES FOR CF |
15-SEP-2005 – 31-MAY-2020 |
||
NIDDK |
UCSF NUTRITION OBESITY RESEARCH CENTER |
1-AUG-2015 – 31-JUL-2020 |
||
NEI |
P30 - CENTER CORE GRANT FOR VISION RESEARCH |
1-MAR-1997 – 30-JUN-2019 |
||
AHRQ |
BUILDING AN AMBULATORY PATIENT SAFETY LEARNING LABORATORY FOR DIVERSE POPULATIONS |
30-SEP-2014 – 29-SEP-2019 |
||
NIMH |
CENTER FOR AIDS PREVENTION STUDIES |
24-SEP-2011 – 31-AUG-2021 |
Specialized Centers (P50) support any part of the full range of research and development from very basic to clinical; may involve ancillary supportive activities such as protracted patient care necessary to the primary research or R&D effort. The spectrum of activities comprises a multidisciplinary attack on a specific disease entity or biomedical problem area. These grants differ from program project grants in that they are usually developed in response to an announcement of the programmatic needs of an Institute or Division and subsequently receive continuous attention from its staff. Centers may also serve as regional or national resources for special research purposes.
Currently Funded P50s at UCSF (last updated July 2019)
Award Number |
Awarding IC |
Title |
PI |
Awarded Period |
NCI |
SPORE: BRAIN TUMORE SPORE GRANT |
20-SEP-2002 – 31-AUG-2023 |
||
FDA |
UCSF PEDIATRIC DEVICE CONSORTIUM |
10-SEP-2014 – 31-AUG-2018 |
||
NIGMS |
EXPLORING DESIGN PRINCIPLES OF CELLULAR CONTROL CIRCUITS |
1-AUG-2010 – 31-JUL-2019 |
||
NIGMS |
HARC CENTER: HIV ACCESSORY AND REGULATORY COMPLEXES |
27-AUG-2007 – 31-AUG-2018 |
||
NICHD |
CENTER FOR RESEARCH, INNOVATION AND TRAINING IN REPRODUCTION AND INFERTILITY |
1-APR-2007 – 31-MAR-2023 |
Research Program--Cooperative Agreements (U19) support a research program of multiple projects directed toward a specific major objective, basic theme or program goal, requiring a broadly based, multidisciplinary and often long-term approach. A cooperative agreement research program generally involves the organized efforts of large groups, members of which are conducting research projects designed to elucidate the various aspects of a specific objective. Substantial Federal programmatic staff involvement is intended to assist investigators during performance of the research activities, as defined in the terms and conditions of award. The investigators have primary authorities and responsibilities to define research objectives and approaches, and to plan, conduct, analyze, and publish results, interpretations and conclusions of their studies. Each research project is usually under the leadership of an established investigator in an area representing his/her special interest and competencies. Each project supported through this mechanism should contribute to or be directly related to the common theme of the total research effort. The award can provide support for certain basic shared resources, including clinical components, which facilitate the total research effort. These scientifically meritorious projects should demonstrate an essential element of unity and interdependence.
Currently Funded U19s at UCSF (last updated Juy 2019)
Award Number |
Awarding IC |
Title |
PI |
Awarded Period |
NIAID |
UNDERSTANDING ASTHMA ENDOTYPES |
1-APR-2008 – 31-MAR-2023 |
||
NIAID |
PROGRAM FOR RESISTANCE, IMMUNOLOGY, SURVEILLANCE & MODELING OF MALARIA IN UGANDA (PRISM) RENEWAL |
1-JUL-2010 – 31-MAR-2024 |
||
NIAID |
HPMI: HOST PATHOGEN MAPPING INITIATIVE |
17-AUG-2018 – 31-JUL-2022 |
||
NCI |
IN VIVO REGULATED RELEASE AND FUNCTION OF EXTRACELLULAR SMALL RNAS |
1-SEP-2013 – 31-AUG-2019 |
||
NCI |
GENETIC MODELS FOR EXRNA COMMUNICATION |
1-SEP-2013 – 31-AUG-2019 |
||
NICHD |
SEQUENCING OF NEWBORN BLOOD SPOT DNA TO IMPROVE AND EXPAND NEWBORN SCREENING |
5-SEP-2013 – 31-AUG-2019 |
||
NINDS |
IMMUNOGENETIC DETERMINANTS OF DISEASE RISK IN NEUROLOGICAL DISEASE |
1-JUL-2015 – 30-JUN-2020 |
Resource-Related Research Projects--Cooperative Agreements (U24) support research projects contributing to improvement of the capability of resources to serve biomedical research.
Currently Funded U24s at UCSF (last updated July 2019)
Award Number |
Awarding IC |
Title |
PI |
Awarded Period |
NIAID |
MULTIPLEX IN SITU GENE EXPRESSION AND PHENOTYPICAL PROFILING OF INFLAMED TISSUES |
26-JUN-2015 – 31-MAY-2020 |
||
NCI |
STANFORD AND NORTHROP GRUMMAN PROPOSAL FOR THE ONCOLOGY MODELS FORUM |
1-SEP-2015 – 31-AUG-2020 |
||
NCI |
THE TOPAS TOOL FOR PARTICLE SIMULATION, A MONTE CARLO SIMULATION TOOL FOR PHYSICS, BIOLOGY AND CLINICAL RESEARCH |
4-JUN-2018 – 31-MAY-2023 |
||
NIDCR |
CENTER FOR DENTAL, ORAL, AND CRANIOFACIAL TISSUE AND ORGAN REGENERATION (C-DOCTOR) |
1-MAR-2017 – 29-FEB-2020 |
||
NIDDK |
ILLUMINATING DRUGGABLE DARK MATTER |
15-SEP-2017 – 31-AUG-2023 |
||
NIGMS |
PGRN ADMINISTRATIVE COORDINATION HUB, ACH (PGRN) |
1-JUL-2015 – 30-JUN-2020 |
||
NINDS |
NORCAL-RCC FOR NORTHERN CALIFORNIA REGIONAL COORDINATING CENTER |
15-AUG-2018 – 31-JUL-2023 |
Specialized Center--Cooperative Agreements (U54) support any part of the full range of research and development from very basic to clinical; may involve ancillary supportive activities such as protracted patient care necessary to the primary research or R&D effort. The spectrum of activities comprises a multidisciplinary attack on a specific disease entity or biomedical problem area. These differ from program project in that they are usually developed in response to an announcement of the programmatic needs of an Institute or Division and subsequently receive continuous attention from its staff. Centers may also serve as regional or national resources for special research purposes, with funding component staff helping to identify appropriate priority needs.
Currently Funded U54s at UCSF (last updated July 2019)
Award Number |
Awarding IC |
Title |
PI |
Awarded Period |
NIAID |
PRIMARY IMMUNE DEFICIENCY TREATMENT CONSORTIUM |
12-SEP-2009 – 31-AUG-2019 |
||
NCI |
UGANDA-UCSF CONSORTIUM ON PREVENTION AND EARLY DETECTION OF HIV-ASSOCIATED CANCER |
17-SEP-2014 – 31-AUG-2020 |
||
NCI |
RESEARCH CENTER FOR CANCER SYSTEMS BIOLOGY: CANCER CELL MAP INITIATIVE |
11-MAY-2017 – 30-APR-2022 |
||
NCI |
BAY AREA TEAM AGAINST RESISTANCE |
30-SEP-2017 – 31-AUG-2019 |
||
NINDS |
BRAIN VASCULAR MALFORMATION CONSORTIUM: PREDICTORS OF CLINICAL COURSE |
30-SEP-2009 – 31-JUL-2019 |
||
NINDS |
THE FRONTOTEMPORAL LOBAR DEGENERATION CLINICAL RESEARCH CONSORTIUM |
30-SEP-2014 – 31-JUL-2019 |
||
HL147127 | NHLBI | INTEGRATED HEALTH, BEHAVIORAL AND ECONOMIC RESEARCH ON CURRENT AND EMERGING TOBACCO PRODUCTS | GLANTZ, STANTON ARNOLD |
19-SEP-2013 – 31-AUG-2019 |